| GALMED PHARMACEUT.IS 1,80 |
| Israel |
| Gesundheit |
| IL0011313900 / A1XFUX |
| GPH (Frankfurt) / GLMD (NASDAQ) |
| FRA:GPH, ETR:GPH, GPH:GR, NASDAQ:GLMD |
| - |
| https://galmedpharma.com/ |
|
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutic solutions in the healthcare industry, particularly focusing on liver diseases. Its primary aim is to addre..
>Volltext.. |
| 2.56 Mio. EUR |
| -14.05 Mio. EUR |
| - |
| -6.16 Mio. EUR |
| -7.54 Mio. EUR |
| -3.05 EUR |
| - |
| 2.98 Mio. EUR |
| -5.49 Mio. EUR |
| 7.76 |
| - |
| -37.57% |
| - |
| - |
| - |
| - |
| GALMED |
| 04.04.26 |
|